Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan García Puig

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Opinion in Rheumatology|March 20, 2008
Hyperuricemia, gout and the metabolic syndromeJuan García Puig, María Angeles Martínez
Medicina Clinica|February 14, 2006
[Home blood pressure measurement]María Angeles Martínez-López, Juan García-Puig,
Vascular Health and Risk Management|December 15, 2007
Comprehensive cardiovascular risk management--what does it mean in practice?Leif Erhardt, Robert Moller, Juan García Puig
Medicina Clinica|July 22, 2010
[Variant phenotype of Lesch-Nyhan syndrome]Rosa Torres Jiménez, Marta García García, Juan García Puig
Nutricion Hospitalaria|July 10, 2013
[Sugar and cardiovascular disease]Luis Gómez Morales, Luis Matías Beltrán Romero, Juan García Puig
Revista Clinica Espanola|January 11, 2011
[Report of the editors, 2010]Juan García Puig, Gabriel Gaspar Alonso-Vega, Juan José Ríos Blanco
The American Journal of Medicine|March 28, 2006
Glucose metabolism in patients with essential hypertensionJuan García-Puig, Luis M Ruilope, Manuel Luque, et al.
Arthritis and Rheumatism|July 9, 2003
Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young womanPablo García-Pavía, Rosa J Torres, Manuel Rivero, et al.
Cardiovascular Drugs and Therapy|May 27, 2003
Clinical profile of eprosartanJuan García Puig, María A Martínez López, Teresa Sancho Bueso, et al.
Vascular Health and Risk Management|January 23, 2015
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusLuis M Beltrán, Alfonso Rubio-Navarro, Juan Manuel Amaro-Villalobos, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Opinion in Rheumatology|March 20, 2008
Hyperuricemia, gout and the metabolic syndromeJuan García Puig, María Angeles Martínez
Medicina Clinica|February 14, 2006
[Home blood pressure measurement]María Angeles Martínez-López, Juan García-Puig,
Vascular Health and Risk Management|December 15, 2007
Comprehensive cardiovascular risk management--what does it mean in practice?Leif Erhardt, Robert Moller, Juan García Puig
Medicina Clinica|July 22, 2010
[Variant phenotype of Lesch-Nyhan syndrome]Rosa Torres Jiménez, Marta García García, Juan García Puig
Nutricion Hospitalaria|July 10, 2013
[Sugar and cardiovascular disease]Luis Gómez Morales, Luis Matías Beltrán Romero, Juan García Puig
Revista Clinica Espanola|January 11, 2011
[Report of the editors, 2010]Juan García Puig, Gabriel Gaspar Alonso-Vega, Juan José Ríos Blanco
The American Journal of Medicine|March 28, 2006
Glucose metabolism in patients with essential hypertensionJuan García-Puig, Luis M Ruilope, Manuel Luque, et al.
Arthritis and Rheumatism|July 9, 2003
Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young womanPablo García-Pavía, Rosa J Torres, Manuel Rivero, et al.
Cardiovascular Drugs and Therapy|May 27, 2003
Clinical profile of eprosartanJuan García Puig, María A Martínez López, Teresa Sancho Bueso, et al.
Vascular Health and Risk Management|January 23, 2015
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusLuis M Beltrán, Alfonso Rubio-Navarro, Juan Manuel Amaro-Villalobos, et al.
Pageof 3